Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)
- 21 April 2010
- journal article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 137 (2), 305-310
- https://doi.org/10.1007/s00432-010-0887-7
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Antitumor activity of cytokine-induced killer cells against human lung cancerInternational Immunopharmacology, 2007
- Enhanced Killing of Primary Ovarian Cancer by Retargeting Autologous Cytokine-Induced Killer Cells with Bispecific Antibodies: A Preclinical StudyClinical Cancer Research, 2006
- Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinomaWorld Journal of Gastroenterology, 2004
- Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphomaBritish Journal of Cancer, 1999
- Cellular immunotherapy and autologous transplantation for hematologic malignancyImmunological Reviews, 1997
- A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.The Journal of Immunology, 1994